Targeting RNA to treat neuromuscular disease.

Targeting RNA to treat neuromuscular disease.

The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Muntoni, F, Wood, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2011

Míreanna comhchosúla

RNA-targeted splice-correction therapy for neuromuscular disease.
de réir: Wood, M, et al.
Foilsithe / Cruthaithe: (2010)

Syncoilin upregulation in muscle of patients with neuromuscular disease.
de réir: Brown, S, et al.
Foilsithe / Cruthaithe: (2005)

Splicing therapy for neuromuscular disease.
de réir: Douglas, A, et al.
Foilsithe / Cruthaithe: (2013)

Syncoilin expression in neuromuscular disorders
de réir: Torelli, S, et al.
Foilsithe / Cruthaithe: (2001)

Syncoilin expression in neuromuscular disorders.
de réir: Howman, E, et al.
Foilsithe / Cruthaithe: (2001)

Establishment and application of clinical biobanks in treating neuromuscular diseases
de réir: Ya-wen ZHAO, et al.
Foilsithe / Cruthaithe: (2016-10-01)

Emerging oligonucleotide therapeutics for rare neuromuscular diseases
de réir: Aoki, Y, et al.
Foilsithe / Cruthaithe: (2021)

Editorial: Genome and transcriptome editing to understand and treat neuromuscular diseases
de réir: Rika Maruyama, et al.
Foilsithe / Cruthaithe: (2023-03-01)

RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
de réir: Buckingham, S, et al.
Foilsithe / Cruthaithe: (2004)

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
de réir: Anja Holm, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Systemic delivery of MicroRNA using recombinant adeno-associated virus serotype 9 to treat neuromuscular diseases in rodents
de réir: Pourshafie, N, et al.
Foilsithe / Cruthaithe: (2018)

Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.
de réir: Jaffer, F, et al.
Foilsithe / Cruthaithe: (2013)

RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
de réir: Veronica Verdile, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders
de réir: Min-Suk Yoon, et al.
Foilsithe / Cruthaithe: (2015-07-01)

Multiple roles of integrin-α3 at the neuromuscular junction.
de réir: Ross, J, et al.
Foilsithe / Cruthaithe: (2017)

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
de réir: Yu-Fu Wu, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
de réir: Kris T Chiles, et al.
Foilsithe / Cruthaithe: (2011-01-01)

Diseases of the neuromuscular junction.
de réir: McConville, J, et al.
Foilsithe / Cruthaithe: (2002)

Diagnosing Neuromuscular Diseases
de réir: Alberto L. Dubrovsky
Foilsithe / Cruthaithe: (2018-08-01)

Neuromuscular Diseases and Bone
de réir: Giovanni Iolascon, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Neuromuscular diseases and anesthesia
de réir: Antonijević Vesna, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
de réir: Gina Picchiarelli, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Protein defects in neuromuscular diseases
de réir: Vainzof M., et al.
Foilsithe / Cruthaithe: (2003-01-01)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
de réir: Mariot, V, et al.
Foilsithe / Cruthaithe: (2017)

Neuromuscular Blockade for Cardiac Arrest Patients Treated With Targeted Temperature Management: A Systematic Review and Meta-Analysis
de réir: Tong Lin, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Critical Illness Neuromuscular Disease
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1995-02-01)

Neuromuscular disease: 2023 update
de réir: Marta Margeta
Foilsithe / Cruthaithe: (2023-02-01)

Modeling neuromuscular diseases in zebrafish
de réir: Jaskaran Singh, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Neuromuscular diseases: revisiting the "overtraining"
de réir: Marco Orsini, et al.
Foilsithe / Cruthaithe: (2014-04-01)

Editorial: Imaging of Neuromuscular Diseases
de réir: Jordi Diaz-Manera, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Management of patients with neuromuscular disease /
de réir: Bach, John R., 1950-
Foilsithe / Cruthaithe: (c200)

Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases
de réir: Léa Lescouzères, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Doenças neuromusculares Neuromuscular disorders
de réir: Umbertina C. Reed
Foilsithe / Cruthaithe: (2002-08-01)

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases
de réir: Judith Cantó-Santos, et al.
Foilsithe / Cruthaithe: (2020-10-01)

Predictors of overload in parents of children with neuromuscular diseases
de réir: A. A. Rodríguez, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
de réir: Vincent, A, et al.
Foilsithe / Cruthaithe: (2000)

Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
de réir: Arimura, S, et al.
Foilsithe / Cruthaithe: (2014)

RNA and glia at the Drosophila neuromuscular junction: importance for synaptic plasticity
de réir: Gala, DS
Foilsithe / Cruthaithe: (2023)

Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
de réir: Robb, SA, et al.
Foilsithe / Cruthaithe: (2011)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
de réir: Virginie Mariot, et al.
Foilsithe / Cruthaithe: (2017-11-01)